Jeannette Liller, NP
Family · Colorado Springs, CONPI 1972966992
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $71,958 of the $74,437 with a category attached, or 96.7%. Medtronic accounts for 98.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $31,743 and has fallen 97.7% since, to $731 in 2025. Among family clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $942.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$74K
- BETA Bionics, Inc.$281
- Dexcom, Inc.$219
- Tandem Diabetes Care, Inc.$119
- Sequel Med Tech, LLC$84
- Amphastar Pharmaceuticals, Inc.$74
- plus $128 from 4 others
What the payments were for
- Speaking & faculty fees$71,95897%
- Travel & lodging$6591%
- Food & beverage$1,8202%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 54 | $73,533 |
| BETA Bionics, Inc. | 7 | $281 |
| Dexcom, Inc. | 4 | $219 |
| Tandem Diabetes Care, Inc. | 5 | $119 |
| Sequel Med Tech, LLC | 2 | $84 |
| Amphastar Pharmaceuticals, Inc. | 1 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| AbbVie | 1 | $30 |
| Abbott | 1 | $20 |
| Insulet Corporation | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$45,440
- MINIMED 770G$15,843
- Minimed 770G System$11,634
- iLet Bionic Pancreas$474
- DEXCOM G7 GSS (161)$149
How this compares
$74,437 in reported general payments places this provider in the 95th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 194 | $398,381 |
| JardianceEmpagliflozin | 189 | $266,522 |
| Tresiba Flextouch U-200Insulin Degludec | 74 | $157,809 |
| OzempicSemaglutide | 97 | $149,164 |
| MounjaroTirzepatide | 78 | $137,922 |
| Tresiba Flextouch U-100Insulin Degludec | 110 | $119,511 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $78,051 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 48 | $66,913 |
| Humalog Kwikpen U-200Insulin Lispro | 16 | $53,298 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 192 | $47,709 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 25 | $46,555 |
| JanuviaSitagliptin Phosphate | 36 | $42,747 |
| BaqsimiGlucagon | 60 | $34,427 |
| FarxigaDapagliflozin Propanediol | 22 | $30,902 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 21 | $29,678 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $30 | $1,70114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,182 family providers in Colorado.
Other family in Colorado Springs
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Barbara ChamnessColorado Springs$15K
- Julie UnruhColorado Springs$14K
- Lisa HutchcraftColorado Springs$13K
- Kristin SekelskyColorado Springs$10K
- Leandrea TzitzicasColorado Springs$9K
- Lisa DudzikColorado Springs$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.